IMARC Group, a leading market research company, has recently releases report titled “Cholera Vaccines Market Report by Vaccine Type (Whole Cell V. Cholerae O1 with Recombinant B-Subunit, Killed Oral O1 and O139), Product (Dukoral, Shanchol, Vaxchora, Euvichol and Euvichol-Plus, and Others), End User (Hospitals and Clinics, Research and Academic Laboratories, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global cholera vaccines market.

How Big is the Cholera Vaccines Market?

The global cholera vaccines market size reached US$ 5.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.

Industry Overview of Cholera Vaccines

Cholera vaccines are biological preparations that assist in strengthening the immune system and provide immunity against cholera. It also helps in minimizing the risk of bacterial infections that may spread through contaminated food and water and leads to abdominal pain, fever, rapid heart rate, loss of skin elasticity, low blood pressure, muscle cramps, and dry mucous membranes. At present, it includes the oral cholera vaccine (OCV) that protects against cholera for up to two years, and the injectable cholera vaccine (ICV), which facilitates prevention for six months.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cholera-vaccines-market/requestsample

What are the growth prospects and trends in the cholera vaccines industry?

The growing global population and increasing focus on prevention and control of cholera in areas with poor sanitation and hygiene currently represent one of the key factors positively influencing the market across the globe.

In addition, governments and private organizations are introducing favorable health initiatives for the prevention and control of infectious diseases like cholera. This, along with the growing awareness about the importance and effectiveness of cholera vaccines among the people, is creating a favorable market outlook.

Apart from this, increasing investments in research and development (R&D) activities for developing new vaccine formulations for cholera, including single-dose vaccines and heat-stable vaccines that do not require refrigeration, are stimulating the growth of the market around the world.

Leading Companies Operating in the Global Cholera Vaccines Industry:

  • Astellas Pharma Inc.
  • Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
  • Emergent BioSolutions Inc.
  • Eubiologics Co. Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer Inc.
  • PharmaChoice Canada Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Valneva SE

Cholera Vaccines Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Vaccine Type:

  • Whole Cell V. Cholerae O1 with Recombinant B-Subunit
  • Killed Oral O1 and O139

Breakup by Product:

  • Dukoral
  • Shanchol
  • Vaxchora
  • Euvichol and Euvichol-Plus
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others

Breakup by Region:

  • North America: (United States, Canada)

  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

  • Latin America: (Brazil, Mexico, Others)

  • Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163